U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Fredrickson Type I Lipidemia

MedGen UID:
163630
•Concept ID:
C0856526
•
Disease or Syndrome

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • CROGVFredrickson Type I Lipidemia

Professional guidelines

PubMed

Rosuvastatin for the treatment of hypercholesterolemia.
Culhane NS, Lettieri SL, Skae JR
Pharmacotherapy 2005 Jul;25(7):990-1000. doi: 10.1592/phco.2005.25.7.990. PMID: 16006277
Prostacyclin synthesis stimulating plasma factor in patients with primary hyperlipoproteinemia--effect of dietary and drug treatment.
Sinzinger H, Kaliman J, Strobl-Jäger E, Widhalm K, Peskar BA
Prostaglandins Leukot Med 1986 May;22(2):179-89. doi: 10.1016/0262-1746(86)90087-9. PMID: 3523539
Neonatal diagnosis of familial type-II hyperlipoproteinaemia.
Kwiterovich PO Jr, Levy RI, Fredrickson DS
Lancet 1973 Jan 20;1(7795):118-21. doi: 10.1016/s0140-6736(73)90194-3. PMID: 4118465

Recent clinical studies

Etiology

Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk.
Das Pradhan A, Glynn RJ, Fruchart JC, MacFadyen JG, Zaharris ES, Everett BM, Campbell SE, Oshima R, Amarenco P, Blom DJ, Brinton EA, Eckel RH, Elam MB, Felicio JS, Ginsberg HN, Goudev A, Ishibashi S, Joseph J, Kodama T, Koenig W, Leiter LA, Lorenzatti AJ, Mankovsky B, Marx N, Nordestgaard BG, Páll D, Ray KK, Santos RD, Soran H, Susekov A, Tendera M, Yokote K, Paynter NP, Buring JE, Libby P, Ridker PM; PROMINENT Investigators
N Engl J Med 2022 Nov 24;387(21):1923-1934. Epub 2022 Nov 5 doi: 10.1056/NEJMoa2210645. PMID: 36342113
Dysbetalipoproteinemia: Differentiating Multifactorial Remnant Cholesterol Disease From Genetic ApoE Deficiency.
Paquette M, Bernard S, Paré G, Baass A
J Clin Endocrinol Metab 2022 Jan 18;107(2):538-548. doi: 10.1210/clinem/dgab648. PMID: 34467996
Dysbetalipoproteinaemia: a mixed hyperlipidaemia of remnant lipoproteins due to mutations in apolipoprotein E.
Marais AD, Solomon GA, Blom DJ
Crit Rev Clin Lab Sci 2014 Feb;51(1):46-62. Epub 2014 Jan 9 doi: 10.3109/10408363.2013.870526. PMID: 24405372
Genetic bases of hypertriglyceridemic phenotypes.
Johansen CT, Hegele RA
Curr Opin Lipidol 2011 Aug;22(4):247-53. doi: 10.1097/MOL.0b013e3283471972. PMID: 21519249
Issues in hyperlipidemic pancreatitis.
Yadav D, Pitchumoni CS
J Clin Gastroenterol 2003 Jan;36(1):54-62. doi: 10.1097/00004836-200301000-00016. PMID: 12488710

Diagnosis

Diagnosis of remnant hyperlipidaemia.
Paquette M, Bernard S, Baass A
Curr Opin Lipidol 2022 Aug 1;33(4):227-230. doi: 10.1097/MOL.0000000000000831. PMID: 35942808
Dysbetalipoproteinemia: an extreme disorder of remnant metabolism.
Marais D
Curr Opin Lipidol 2015 Aug;26(4):292-7. doi: 10.1097/MOL.0000000000000192. PMID: 26103610
Dysbetalipoproteinaemia: a mixed hyperlipidaemia of remnant lipoproteins due to mutations in apolipoprotein E.
Marais AD, Solomon GA, Blom DJ
Crit Rev Clin Lab Sci 2014 Feb;51(1):46-62. Epub 2014 Jan 9 doi: 10.3109/10408363.2013.870526. PMID: 24405372
Genetic bases of hypertriglyceridemic phenotypes.
Johansen CT, Hegele RA
Curr Opin Lipidol 2011 Aug;22(4):247-53. doi: 10.1097/MOL.0b013e3283471972. PMID: 21519249
Issues in hyperlipidemic pancreatitis.
Yadav D, Pitchumoni CS
J Clin Gastroenterol 2003 Jan;36(1):54-62. doi: 10.1097/00004836-200301000-00016. PMID: 12488710

Therapy

Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk.
Das Pradhan A, Glynn RJ, Fruchart JC, MacFadyen JG, Zaharris ES, Everett BM, Campbell SE, Oshima R, Amarenco P, Blom DJ, Brinton EA, Eckel RH, Elam MB, Felicio JS, Ginsberg HN, Goudev A, Ishibashi S, Joseph J, Kodama T, Koenig W, Leiter LA, Lorenzatti AJ, Mankovsky B, Marx N, Nordestgaard BG, Páll D, Ray KK, Santos RD, Soran H, Susekov A, Tendera M, Yokote K, Paynter NP, Buring JE, Libby P, Ridker PM; PROMINENT Investigators
N Engl J Med 2022 Nov 24;387(21):1923-1934. Epub 2022 Nov 5 doi: 10.1056/NEJMoa2210645. PMID: 36342113
Rosuvastatin for the treatment of hypercholesterolemia.
Culhane NS, Lettieri SL, Skae JR
Pharmacotherapy 2005 Jul;25(7):990-1000. doi: 10.1592/phco.2005.25.7.990. PMID: 16006277
Update on fenofibrate.
Guay DR
Cardiovasc Drug Rev 2002 Winter;20(4):281-302. doi: 10.1111/j.1527-3466.2002.tb00098.x. PMID: 12481201
Hemorheology and tissue oxygenation in hypertensives with lipoidoproteinosis and peripheral occlusive arterial disease (POAD) treated with sulodexide and pravastatine and evaluated with laser assisted optical rotational red cell analyzer (LORCA) and transcutaneous oxymetry.
Cicco G, Stingi GD, Vicenti P, Tarallo MS, Pirrelli A
Minerva Cardioangiol 1999 Oct;47(10):351-9. PMID: 10670256
Apolipoprotein E and complement C3 polymorphism and their role in the response to gemfibrozil and low fat low cholesterol therapy.
Nemeth A, Szakmary K, Kramer J, Dinya E, Pados G, Fust G, Huettinger M
Eur J Clin Chem Clin Biochem 1995 Nov;33(11):799-804. doi: 10.1515/cclm.1995.33.11.799. PMID: 8620056

Prognosis

Dysbetalipoproteinaemia: a mixed hyperlipidaemia of remnant lipoproteins due to mutations in apolipoprotein E.
Marais AD, Solomon GA, Blom DJ
Crit Rev Clin Lab Sci 2014 Feb;51(1):46-62. Epub 2014 Jan 9 doi: 10.3109/10408363.2013.870526. PMID: 24405372
Increased hair selenium concentration in hyperlipidemic patients.
Fülöp P, Seres I, Jenei Z, Juhász I, Paragh G
J Cell Mol Med 2013 Mar;17(3):350-5. Epub 2013 Feb 13 doi: 10.1111/jcmm.12013. PMID: 23402643Free PMC Article
Issues in hyperlipidemic pancreatitis.
Yadav D, Pitchumoni CS
J Clin Gastroenterol 2003 Jan;36(1):54-62. doi: 10.1097/00004836-200301000-00016. PMID: 12488710
Apolipoprotein E and complement C3 polymorphism and their role in the response to gemfibrozil and low fat low cholesterol therapy.
Nemeth A, Szakmary K, Kramer J, Dinya E, Pados G, Fust G, Huettinger M
Eur J Clin Chem Clin Biochem 1995 Nov;33(11):799-804. doi: 10.1515/cclm.1995.33.11.799. PMID: 8620056
Hyperlipidaemia, alcohol abuse and acute pancreatitis.
Dickson AP, O'Neill J, Imrie CW
Br J Surg 1984 Sep;71(9):685-8. doi: 10.1002/bjs.1800710913. PMID: 6206908

Clinical prediction guides

Dysbetalipoproteinaemia: a mixed hyperlipidaemia of remnant lipoproteins due to mutations in apolipoprotein E.
Marais AD, Solomon GA, Blom DJ
Crit Rev Clin Lab Sci 2014 Feb;51(1):46-62. Epub 2014 Jan 9 doi: 10.3109/10408363.2013.870526. PMID: 24405372
Increased hair selenium concentration in hyperlipidemic patients.
Fülöp P, Seres I, Jenei Z, Juhász I, Paragh G
J Cell Mol Med 2013 Mar;17(3):350-5. Epub 2013 Feb 13 doi: 10.1111/jcmm.12013. PMID: 23402643Free PMC Article
Genetic bases of hypertriglyceridemic phenotypes.
Johansen CT, Hegele RA
Curr Opin Lipidol 2011 Aug;22(4):247-53. doi: 10.1097/MOL.0b013e3283471972. PMID: 21519249
Apolipoprotein E and complement C3 polymorphism and their role in the response to gemfibrozil and low fat low cholesterol therapy.
Nemeth A, Szakmary K, Kramer J, Dinya E, Pados G, Fust G, Huettinger M
Eur J Clin Chem Clin Biochem 1995 Nov;33(11):799-804. doi: 10.1515/cclm.1995.33.11.799. PMID: 8620056
The low density lipoprotein receptor.
Schneider WJ
Biochim Biophys Acta 1989 May 9;988(2):303-17. doi: 10.1016/0304-4157(89)90023-3. PMID: 2655710

Supplemental Content

Table of contents

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Related information

    • PMC Articles
      Related information in PubMed Central Links
    • PubMed
      Related literature resources in PubMed

    Recent activity

    Clear Turn Off Turn On

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...